Platelet factor 4(PF 4) in septicaemiaLORENZ, R; BRAUER, M.Infection. 1988, Vol 16, Num 5, pp 273-276, issn 0300-8126Article

Mécanisme d'action du facteur plaquettaire 4 dans la régulation négative de l'hématopoïèse : rôle des régions C-terminale et centrale du PF4. Etude réalisée grâce à la mise au point d'un système d'analyse d'image permettant le comptage automatique des colonies de mégacaryocytes = Mechanism of action of platelet factor 4 in the negative regulation of hematopoiesis : role of the PF4 C-terminal and central regions. Quantitation of megacaryocytopoiesis by computerized automatic image analysisLecomte Raclet, Laurence; Lecomie Raclet, Laurence; Han, Zhong Chao et al.1998, 192 p.Thesis

Platelet factor 4, β-thromboglobulin and thrombospondin levels in type I diabetes mellitus patientsBAYRAKTAR, M; DÜNDAR, S; KIRAZLI, S et al.Journal of international medical research. 1994, Vol 22, Num 2, pp 90-94, issn 0300-0605Article

Modulation of protein C inhibitor activity by histidine-rich glycoprotein and platelet factor 4 : role of zinc and calcium ions in the heparin-neutralizing ability of histidine-rich glycoproteinKAZAMA, Y; KOIDE, T.Thrombosis and haemostasis. 1992, Vol 67, Num 1, pp 50-55, issn 0340-6245Article

Neutralization of the antiheparin activity of platelet factor 4 by a monoclonal antibodySAGGIN, L; CAZZOLA, F; CORONA, G et al.Thrombosis and haemostasis. 1992, Vol 67, Num 1, pp 137-143, issn 0340-6245Article

Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis : Clinical and therapeutic implications. CommentaryLEAVITT, Andrew D; LAMBERT, Michele P; RAUOVA, Lubica et al.Blood. 2007, Vol 110, Num 4, issn 0006-4971, 1090, 1153-1160 [9 p.]Article

Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor―related protein 1 (LRP1) on megakaryocytesLAMBERT, Michele P; YUHUAN WANG; BDEIR, Khalil H et al.Blood. 2009, Vol 114, Num 11, pp 2290-2298, issn 0006-4971, 9 p.Article

Recombinant platelet factor 4 for heparin neutralizationMIXON, Timothy A; DEHMER, Gregory J.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 3, pp 369-377, issn 0094-6176, 9 p.Article

Selection of an HEL-derived cell line expressing high levels of platelet factor 4RAVID, K; KUTER, D. J; BEELER, D. L et al.Blood. 1993, Vol 81, Num 11, pp 2885-2890, issn 0006-4971Article

Platelet function in diabetic retinopathy : levels of β-thromboglobulin and platelet factor 4FENANDEZ-VIGO, J; CORDIDO, M; FERNANDEZ SABUGAL, J et al.Metabolic, pediatric and systemic ophthalmology (1982). 1992, Vol 15, Num 1-3, pp 5-8, issn 0277-9382Conference Paper

Uptake and processing of human platelet factor 4 by hepatocytesRUCINSKI, B; STEWART, G. J; DE FEO, P. A et al.Proceedings of the Society for Experimental Biology and Medicine. 1987, Vol 186, Num 3, pp 361-367, issn 0037-9727Article

Disruption of PF4/H multimolecular complex formation with a minimally anticoagulant heparin (ODSH)JOGLEKAR, Manali V; QUINTANA DIEZ, Pedro M; MARCUS, Stephen et al.Thrombosis and haemostasis. 2012, Vol 107, Num 4, pp 717-725, issn 0340-6245, 9 p.Article

Chemokine regulation of human megakaryocytopoiesisGEWIRTZ, A. M; JIN ZHANG; RATAJCZAK, J et al.Blood. 1995, Vol 86, Num 7, pp 2559-2567, issn 0006-4971Article

Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cellsVISENTIN, G. P; FORD, S. E; SCOTT, J. P et al.The Journal of clinical investigation. 1994, Vol 93, Num 1, pp 81-88, issn 0021-9738Article

Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assayGREINACHER, A; AMIRAL, J; DUMMEL, V et al.Transfusion (Philadelphia, PA). 1994, Vol 34, Num 5, pp 381-385, issn 0041-1132Article

Filtration of platelet-poor plasma specimens yields platelet-free plasma : application for batch analysis of beta-thromboglobulin and platelet factor 4SCHIEBOUT-CLARK, R. C; HAVEN, M. C; HAIRE, W. D et al.American journal of clinical pathology. 1990, Vol 94, Num 2, pp 206-210, issn 0002-9173Article

Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesionZHIHUA XIAO; VISENTIN, Gian P; DAYANANDA, Kannayakanahalli M et al.Blood. 2008, Vol 112, Num 4, pp 1091-1100, issn 0006-4971, 10 p.Article

Determinants of PF4/heparin immunogenicitySUVARNA, Shayela; ESPINASSE, Benjamin; RUI QI et al.Blood. 2007, Vol 110, Num 13, pp 4253-4260, issn 0006-4971, 8 p.Article

Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopeniaZIPOREN, L; LI, Z. Q; PARK, K. S et al.Blood. 1998, Vol 92, Num 9, pp 3250-3259, issn 0006-4971Article

Platelet factor 4 mRNA expression in humlan erythroleukemic cells : regulation by phorbol esters anc certain cytokinesHUNT, P; HOKOM, M. M; FISHER, C. A et al.Experimental hematology. 1991, Vol 19, Num 8, pp 779-784, issn 0301-472XArticle

Platelet factor 4 gene expression in a human megakaryocytic leukemia cell line (CMK) and its differentiated subclone (CMK11-5)ADACHI, M; RYO, R; SATO, T et al.Experimental hematology. 1991, Vol 19, Num 9, pp 923-927, issn 0301-472XArticle

In vitro studies of secretion of platelet factor 4 and generation of fibrinopeptid A in native whole bloodLORENZ, R; GEBHART, S; HEPTNER, W et al.Thrombosis research. 1988, Vol 50, Num 1, pp 231-235, issn 0049-3848Article

Association of natural anti-platelet factor 4/heparin antibodies with periodontal diseaseGREINACHER, Andreas; HOLTFRETER, Birte; KRAUEL, Krystin et al.Blood. 2011, Vol 118, Num 5, pp 1395-1401, issn 0006-4971, 7 p.Article

Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgeryEVERETT, Brendan M; YEH, Robert; JANG, Ik-Kyung et al.The Annals of thoracic surgery. 2007, Vol 83, Num 2, pp 592-597, issn 0003-4975, 6 p.Article

Etude des effets du facteur plaquettaire 4 et des glycosaminoglycanes sur les cellules humaines erythroleucémiques HEL in vitro = Effects of platelet factor 4 and glycosaminoglycans on human erythroleukemic HEL cells in vitroMaurer, Anne-Marie; Briere, J.1995, 147 p.Thesis